I believe WARP speed is good if you start from pre clinical stage or phase 1. But we already in final stages and got fast track, priority review so DMC had completed first interim review in July and 2nd interim review on data will be done soon they will likely recommend FDA to accelerate approval or emergency approval based on efficacy.